Preprint tracker

Most active topics

Preprints in the window that matched each object's literature query. Counts overlap: one preprint can match a target and its drug.

Now published

Journal articles from the last 18 months that Europe PMC links back to a preprint on one of these topics. The journal version is the one to cite; the preprint shows how the claim started.

1. Nucleolar dynamics are determined by the ordered assembly of the ribosome.published
   2026-09-09· Sheu-Gruttadauria J et al.preprint versionNPM1 mutation
2. PDGFRA amplification could be a poor prognostic factor of advanced undifferentiated pleomorphic sarcoma in a comprehensive genomic profiling cohort.published
   2026-09-07· Kobayashi H et al.preprint versionPazopanib
3. Oral Nicotine Pouches and Public Health: Evidence from an Updated Scoping Review.published
   2026-09-06· Travis N et al.preprint versionAzacitidineDecitabine + cedazuridine
4. Redefining NSTE-ACS risk assessment: The synergistic power of CT-enhanced GRACE 2.0 score for advanced prognosis.published
   2026-09-06· Ma JW et al.preprint versionCytarabine + anthracycline
5. A multicenter retrospective study on the clinical features of patients with human epidermal growth factor receptor 2-positive colorectal cancer (HGCSG2304).published
   2026-09-05· Kaneko S et al.preprint versionBevacizumabPertuzumabBevacizumab
6. Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia.published
   2026-09-04· Zinz R et al.preprint versionNPM1 mutation
7. Annexin A2 associated with bevacizumab resistance and infiltrative escape in glioblastoma.published
   2026-09-03· Ezaki T et al.preprint versionBevacizumabBevacizumab
8. The RNA-binding protein La/SSB is associated with HNSCC progression and TFAP2C/FSCN1-linked transcriptional regulation.published
   2026-09-03· Liu S et al.preprint versionCisplatin
9. From toxicity to immunity: Evaluating CAR-T and conventional therapies in multiple myeloma through quality-adjusted life year (QALY) outcomes.published
   2026-09-03· Itez GG et al.preprint versionCarfilzomibDaratumumab
10. Castration-resistant prostate cancer cells are addicted to the high activity of cyclin-dependent kinase 2.published
    2026-09-02· Chatterjee J et al.preprint versionDocetaxelCisplatin
11. Laser interstitial thermal therapy in pediatric neurosurgery: a prospective nationwide study on indications, safety, and early outcomes.published
    2026-09-02· Nielsen SH et al.preprint versionLaser interstitial thermal therapy
12. Intratumoral Administration of Recombinant Murine Interleukin-12 Prevents Tumor Progression and Bone Invasion.published
    2026-09-02· Kasahara S et al.preprint versionPertuzumabAzacitidineDecitabine + cedazuridine
13. SLFN11 enhances cisplatin sensitivity in pediatric cancer via activation of stress-response and suppression of survival pathways.published
    2026-09-02· Jabeen A et al.preprint versionCisplatin
14. Biochanin A inhibits the activity of androgen receptor mutants to suppress the development of prostate cancer.published
    2026-09-01· Chi YN et al.preprint versionEnzalutamide
15. Engineered matrices reveal sulfation-mediated stress adaptation and drug-specific modulation of chemotherapeutic response.published
    2026-09-01· Sarıca S et al.preprint versionCisplatin
16. 2-Mercaptoethanol/DMSO Workflow Enables Highly Reproducible Quantitative Proteomics.published
    2026-09-01· Suto A et al.preprint versionCisplatin
17. Safety and Clinical Outcomes of a First-in-Human Trial of Point-of-Care Manufactured Trispecific CAR T Cells Targeting CD19, CD20, and CD22.published
    2026-09-01· Vasu S et al.preprint versionCD22
18. IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.published
    2026-09-01· Arribas AJ et al.preprint versionBTKIbrutinibRituximab
19. Promiscuous RNA binding by WDR5 remodels the KMT2A (MLL1) histone methyltransferase complex to an inactive state.published
    2026-08-31· Kainth AS et al.preprint versionKMT2A
20. Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated Degradation.published
    2026-08-31· Zhang L et al.preprint versionKRAS
21. Global Hypomethylation in Cell-Free DNA Enables Noninvasive Colorectal Cancer Screening: Results from a Retrospective Validation Study.published
    2026-08-28· Kaur S et al.preprint versionColorectal cancer screening
22. Bladder preservation with disitamab vedotin plus PD-1 inhibitors and local intensification in muscle-invasive bladder cancer: a single-center retrospective cohort of 81 patients.published
    2026-08-28· Chen Y et al.preprint versionIntravesical BCG
23. circBIRC6 regulates cisplatin resistance of choroidal melanoma via positively modulating ERK by sponging miR-503-3p.published
    2026-08-28· Li W et al.preprint versionCisplatin
24. Doxorubicin-induced Cardiotoxicity is Propagated by Paracrine Signaling through Small Extracellular Vesicles.published
    2026-08-28· Ronan G et al.preprint versionDoxorubicin
25. Pregnancy and neonatal outcomes in patients treated for glioma before or during pregnancy: a single-institution retrospective series.published
    2026-08-27· Valerius AR et al.preprint versionTemozolomide
26. A predictive nomogram model for overall survival in obstructive colorectal cancer based on clinical and laboratory indicators.published
    2026-08-27· Lu P et al.preprint versionCytarabine + anthracycline
27. Cheminformatic identification of small molecules targeting acute myeloid leukemia.published
    2026-08-27· Daneman MR et al.preprint versionMidostaurinDoxorubicin
28. Small-molecule RAS/RAF inhibitors target RAS-driven cancers via allosteric RAF disruption.published
    2026-08-27· Yoshikawa Y et al.preprint versionKRAS
29. Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial.published
    2026-08-26· Cabanillas ME et al.preprint versionLenvatinib
30. Targeting endoplasmic reticulum stress to attenuate cisplatin resistance in non-small cell lung cancer.published
    2026-08-24· Celikten S et al.preprint versionNintedanibCisplatin
31. Targeting CDK7 to overcome hypomethylating agent resistance in acute myeloid leukemia.published
    2026-08-24· Koo BK et al.preprint versionAzacitidine
32. Autophagy-associated exosomal microRNAs in triple-negative breast cancer: a discovery-phase study.published
    2026-08-22· Choudhary A et al.preprint versionDoxorubicin
33. Surgical Complexity and Perioperative Feasibility Following Neoadjuvant Chemotherapy, Chemoradiotherapy, or Chemoimmunotherapy in Stage II-III Non-Small Cell Lung Cancer: A Retrospective Single-Institution Study.published
    2026-08-21· Sakai H et al.preprint versionNintedanib
34. From optimistic to overwhelmed: exploring health beliefs and barriers to oral anticancer medication adherence among cancer survivors.published
    2026-08-21· Wen MJ et al.preprint versionAzacitidineDecitabine + cedazuridine
35. Sweet interference: oral fermentation volatile confounders in exhaled breath revealed by minimal glucose exposure.published
    2026-08-21· Chawaguta A et al.preprint versionAzacitidineDecitabine + cedazuridine
36. First-Line Maintenance Therapy Patterns in BRCA Wild-Type, HRD-Negative or Biomarker-Unknown Advanced Epithelial Ovarian Cancer: A Five-Country European Real-World Study by APLUSA.published
    2026-08-19· Uccello M et al.preprint versionActive surveillanceBevacizumabBevacizumabRucaparib
37. Early-onset, treatment-cycle-linked hyperinsulinaemic insulin resistance during capivasertib therapy: a case report.published
    2026-08-19· Motai Y et al.preprint versionFulvestrantAzacitidineDecitabine + cedazuridine
38. Evaluation of the biodistribution of [<sup>99m</sup>Tc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [<sup>68</sup>Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy.published
    2026-08-18· Novruzov E et al.preprint versionGallium-68 gozetotide
39. Risk-adapted intervals for colorectal cancer screening using fecal immunochemical tests: a modelling study based on the BLITZ cohort.published
    2026-08-18· Heisser T et al.preprint versionColorectal cancer screening
40. DUSP12 Regulates NAT10-Mediated RNA Acetylation to Modulate DNA Repair and Therapeutic Response in Hepatocellular Carcinoma.published
    2026-08-17· Boell VK et al.preprint versionCisplatinDoxorubicin
41. Evaluation of anti-arthritic activity of aripiprazole through multi models: new potential of an old drug.published
    2026-08-17· Akber A et al.preprint versionAzacitidineDecitabine + cedazuridine
42. Integrative bulk and single-cell transcriptomics identify a recurrence-prognostic risk model with exploratory associations with treatment-response phenotypes in colorectal cancer.published
    2026-08-17· Li S et al.preprint versionKRAS
43. Relative Dose Intensity and Clinical Outcomes of Using Trifluridine/Tipiracil with or without Bevacizumab in Patients Aged ≥ 75 Years with Advanced or Recurrent Colorectal Cancer: a Single-Center Retrospective Study.published
    2026-08-14· Tomiuchi A et al.preprint versionBevacizumabBevacizumabTrifluridine/tipiracil
44. Multimodal profiling of pro-inflammatory protease activity identifies caspase-1 as a target for lung cancer interception.published
    2026-08-14· Wang CS et al.preprint versionKRAS
45. iPSC-derived polyvalent vaccines as ontogenetically informed immunogens toward overcoming immune refractoriness in microsatellite-stable colorectal cancer: An emerging frontier in cancer immunotherapy.published
    2026-08-13· Kumar A et al.preprint versionKRAS
46. Frailty prediction in heart failure patients with acute infections: the potential role of thiazide diuretics?published
    2026-08-12· Huang T et al.preprint versionCytarabine + anthracycline
47. Integrated Chemical, Computational, and Cellular Profiling of a Dual-Oil Melanoma Formulation: An Exploratory Life-Science Study.published
    2026-08-11· Dunjic K et al.preprint versionCisplatin
48. USP8 controls proteostasis pathways in B cells and multiple myeloma.published
    2026-08-11· Dufner A et al.preprint versionBortezomib
49. Biomarkers Correlating With the Development of Oral Squamous Cell Carcinoma From Leukoplakia.published
    2026-08-10· Giglio D et al.preprint versionAzacitidineDecitabine + cedazuridine
50. Benchmarking Deep Learning for NSCLC PET/CT Segmentation on a Histologically Confirmed Vietnamese Dataset: Validation and Generalization.published
    2026-08-08· Ho QT et al.preprint versionNintedanib
51. DNA Polymerase Beta Catalytic and Fidelity Mutations Drive Platinum-Specific Drug Sensitivity.published
    2026-08-07· Lindquist J et al.preprint versionCisplatin
52. Colonoid-Based Transcriptomics Reveals Conserved and Model-Specific Mechanisms of Doxorubicin-Induced Intestinal Toxicity.published
    2026-08-07· Lodhi S et al.preprint versionDoxorubicin
53. Challenges and Opportunities of γδ T Cell-Based Immunotherapy for Glioblastoma.published
    2026-08-06· Chao CC et al.preprint versionTemozolomide
54. PKM2 Inhibitors Induce Autophagic Cell Death Through Suppression of PKM2-Mediated Glycolysis in Cisplatin-Resistant Ovarian Cancer Cells.published
    2026-08-06· Park HE et al.preprint versionCisplatin
55. Longitudinal echocardiographic systolic changes in dogs receiving doxorubicin-based chemotherapy.published
    2026-08-06· Herrera GC et al.preprint versionDoxorubicin
56. TET2-driven demethylation of ANG promotes angiogenesis and malignant transformation in oligodendroglioma.published
    2026-08-05· Jin J et al.preprint versionTemozolomide
57. A perforator-based adipocutaneous skin paddle derived from free muscle flap reconstruction as a hypothesis-generating human tissue model of early localized lymphatic insufficiency.published
    2026-08-05· Koll KK et al.preprint versionPertuzumab
58. M1C is a druggable target for NSCLC KRAS G12C mutant tumors resistant to KRAS inhibitors.published
    2026-08-05· Takamori S et al.preprint versionNintedanibKRAS
59. TSTScope Unifies Single-Cell Multi-Omics to Identify Functional T Cell States Predictive of Immunotherapy Response.published
    2026-08-05· Cao S et al.preprint versionNintedanib
60. BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation Feasibility.published
    2026-08-05· Candan O et al.preprint versionAllogeneic stem cell transplantation
61. Predictive value of TTF-1 expression for stratifying outcomes between dual ICI and chemoimmunotherapy in patients with PD-L1-negative NSCLC.published
    2026-08-04· Nishioka N et al.preprint versionNintedanib
62. Metabolic CRISPR screening identifies RPE as a key regulator of acquired enzalutamide resistance through FKBP5 destabilization in prostate cancer.published
    2026-08-03· Hu J et al.preprint versionEnzalutamide
63. A dimer peptide ligand of vascular endothelial growth factor slows the progression of human gastric tumors in mouse xenografts.published
    2026-08-03· Ye X et al.preprint versionBevacizumabBevacizumab
64. MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer.published
    2026-08-01· Liu W et al.preprint versionEnzalutamide
65. Adaptation of White Adipocytes to Cooler Temperatures: Impacts on Energy Metabolism and Protein Acetylation.published
    2026-08-01· Mori H et al.preprint versionPertuzumab
66. Emergency management protocols for major complications after oral and maxillofacial surgery: emphasis on airway and bleeding control.published
    2026-08-01· Lee S et al.preprint versionAzacitidineDecitabine + cedazuridine
67. Direct Small Molecule Modulation of LILRB4 (ILT3) Restores Antitumor Immunity In Vivo and in Patient-Derived Cells.published
    2026-08-01· Abdel-Rahman SA et al.preprint versionAzacitidineDecitabine + cedazuridine
68. Shape, shrink, spheroid: a DIY high-throughput spheroid generation device.published
    2026-07-31· Mogha P et al.preprint versionTemozolomide
69. Radio-sensitization of mutated KRAS G12C non-small cell lung cancer with KRAS G12C tyrosine kinase inhibitor and carbon ions irradiation.published
    2026-07-31· Césaire M et al.preprint versionNintedanibKRAS
70. The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming.published
    2026-07-30· Cole AR et al.preprint versionCisplatin
71. PROTAC-mediated targeting of IKKβ and NR4A1 for AML therapy.published
    2026-07-30· Maharjan CK et al.preprint versionKMT2A
72. Notch2 signaling instructs viral and bacterial TLR responsiveness in B cells.published
    2026-07-30· Londregan J et al.preprint versionBTK
73. Combined Exposure to 1,2-Dichloropropane and Dichloromethane Enhances Hepatocellular Tumor Development in Mice.published
    2026-07-30· Gi M et al.preprint versionAzacitidineDecitabine + cedazuridine
74. Hypoxia-induced metastatic heterogeneity in pancreatic cancer.published
    2026-07-30· Gunasekaran PM et al.preprint versionKRAS
75. AP-1 mediated chromatin changes govern alveolar type 2 cell transition in lung injury-repair.published
    2026-07-30· Lynch AM et al.preprint versionKRAS
76. Dual targeting of BCL-XL and MCL-1 exposes a rapid and exploitable apoptotic vulnerability in non-small cell lung cancer.published
    2026-07-29· Wu L et al.preprint versionNintedanibCisplatin
77. A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.published
    2026-07-28· Zaalberg A et al.preprint versionEnzalutamide
78. Kinase Plasticity with Vandetanib Treatment Enhances Sensitivity to Tamoxifen in Estrogen Receptor Positive Breast Cancer.published
    2026-07-28· Whitman AA et al.preprint versionTamoxifenLapatinibVandetanib
79. Disparities in colonoscopy adherence and neoplasia detection after positive fecal immunochemical test: a retrospective matched cohort study.published
    2026-07-28· Chaparro S et al.preprint versionColorectal cancer screening
80. Clinical evaluation of non-intubated spontaneous ventilation video-assisted thoracoscopic surgery in patients with non-small cell lung cancer and compromised pulmonary function: a propensity score-matched analysis.published
    2026-07-28· Zheng X et al.preprint versionNintedanib

Latest preprints, all topics

1. Transcriptome profiling of cell-free RNAs in prostate cancer patients on active surveillancepreprint
   2026-09-09· bioRxiv· Foster JG et al.Active surveillance
2. Novel Target Combinations in Lung Squamous Cell Carcinoma proposed by the Emet AI Research Environment and supported by discovery stage experimentationpreprint
   2026-09-09· bioRxiv· Soman J et al.Alpelisib
3. Methyl-substituted 1,10-phenanthroline derivatives in copper(II) complexes enhance antitumor activity and inhibit NHE1 in MDA-MB-231 breast cancer cellspreprint
   2026-09-09· bioRxiv· Munoz Garzon KS et al.Cisplatin
4. Formulation and Optimization of Catechin-Loaded Niosomes for Improved Pharmacokinetic Performancepreprint
   2026-09-09· Research Square· Devne SR et al.CisplatinAzacitidineDecitabine + cedazuridine
5. Rapid diagnostics of actionable mutations in acute myeloid leukemia using amplicon nanopore sequencingpreprint
   2026-09-09· Research Square· Östlund R et al.NPM1 mutation
6. p140Cap guides personalized combination strategies with anti-PD-L1 immunotherapy in HER2+ and triple-negative breast cancerpreprint
   2026-09-09· Research Square· Scavuzzo A et al.Doxorubicin
7. CPD4 Reverses Chemoresistance and Suppresses Cancer Stem Cell Phenotypes in Triple-Negative Breast Cancer via ROR1 Inhibitionpreprint
   2026-09-09· Research Square· Ta TM et al.Doxorubicin
8. Oncogene Driver Status Modulates TP53 Prognostic Impact in Advanced NSCLCpreprint
   2026-09-08· medRxiv· Pan M et al.ROS1Nintedanib
9. Management of biopsy proven lymph node metastases from papillary thyroid cancer under active surveillance protocolspreprint
   2026-09-08· Research Square· Tramontin MY et al.Active surveillance
10. PSMA PET SUVmax Adds Information Beyond Conventional Risk Indices in Localized Prostate Cancer: A Prospective Lesion-Level Radiopathologic Studypreprint
    2026-09-08· medRxiv· Motchoffo Simo G( et al.Multiparametric prostate MRI
11. First-in-human evaluation of 225Ac-PSMA-Trillium™ (BAY 3563254; 225Ac felivotide mopaxetan) in metastatic castration-resistant prostate cancer: the phase 1 PAnTHA studypreprint
    2026-09-08· Research Square· Saad F et al.Radium-223 dichloride
12. Study of Tumor Mutational Changes Assessed by NGS in Patients with BRAF-Mutated Metastatic Colorectal Cancer Undergoing Surgical Resection After Prior Systemic Therapypreprint
    2026-09-08· Preprints.org· Soto Alsar J et al.BevacizumabPanitumumabBevacizumab
13. Analytical Quality by Design (AQbD)-Based Development and Validation of a Robust RP-HPLC Method for Quantification of Regorafenib in Bulk Drug and Tablet Dosage Formpreprint
    2026-09-08· Research Square· Chaudhary P et al.Regorafenib
14. Cabozantinib reshapes the CD4+ T-cell exhaustion program in clear cell renal cell carcinoma through multi-target kinase inhibition and cytokine remodelingpreprint
    2026-09-08· Research Square· Domanski P et al.Cabozantinib
15. Recent Trends in p16-Positive Oropharyngeal Squamous Cell Carcinoma in Northern Israelpreprint
    2026-09-08· Research Square· Biterman-Fisher S et al.Cetuximab
16. Chemotherapy-induced immunogenic hub restores NK cell activity via P2X7R in NSCLCpreprint
    2026-09-08· Research Square· Bedeschi M et al.PemetrexedNintedanibCisplatin
17. Targeting fibroblast activation suppresses chemotherapy-induced pro-invasive remodeling of the extracellular matrixpreprint
    2026-09-08· bioRxiv· Yui A et al.NintedanibDoxorubicin
18. A cyclooxygenase-2 associated pro-tumorigenic inflammatory signature predicts outcome after surgery in lung cancerpreprint
    2026-09-08· medRxiv· Fife V et al.Nintedanib
19. Association of clinicopathological features with spread through air spaces in non-small cell lung cancer: a retrospective machine-learning studypreprint
    2026-09-08· Research Square· Laptev N et al.Nintedanib
20. Effects of VR-CALM on cancer-related fatigue, psychological distress and related symptoms in patients with non-small cell lung cancer: a randomised controlled trialpreprint
    2026-09-08· Research Square· Ling M et al.Nintedanib
21. The association between emotional distress and the efficacy of immune checkpoint inhibitor therapy in cancer patients: a systematic review and meta-analysispreprint
    2026-09-08· Research Square· Chen J et al.Nintedanib
22. The First Experience of Accelerator-based Lithium Neutron Capture Therapy in vivopreprint
    2026-09-08· bioRxiv· Taskaeva I et al.AzacitidineDecitabine + cedazuridine
23. Factor XI and XIa Inhibitors: A State-of-the-Art Review Across Clinical Indicationspreprint
    2026-09-08· Preprints.org· Oikonomou E et al.AzacitidineDecitabine + cedazuridine
24. An oncolytic reovirus-based platform amenable to oral vaccinationpreprint
    2026-09-08· Research Square· Pashangzadeh S et al.AzacitidineDecitabine + cedazuridine
25. Coexisting multiple types of gynecological tumors and primary amenorrhea in an adolescent with Proteus syndrome: A case reportpreprint
    2026-09-08· Research Square· Sun Y et al.AzacitidineDecitabine + cedazuridine
26. Mechanism-guided Mn 3 O 4 /GDY nanoplatform intercepts neutrophil- driven oxidative amplification to treat inflammatory bowel diseasepreprint
    2026-09-08· Research Square· An Z et al.AzacitidineDecitabine + cedazuridine
27. CAMOR and specific oncogene-driven lncRNAs mediate carcinogenic functions downstream of MYC, mutant KRAS, and mutant TP53preprint
    2026-09-08· bioRxiv· Grzes M et al.KRAS
28. Clinicopathologic profile and comparative performance of limited next-generation sequencing and quantitative/real-time polymerase chain reaction for detection of RAS/RAF mutations in metastatic colorectal cancerpreprint
    2026-09-08· Research Square· Dubey A et al.KRAS
29. Two largely independent axes of drug transcriptional response in Tahoe-100Mpreprint
    2026-09-08· Research Square· Shen H.KRAS
30. The RNA cargo of plasma-derived extracellular vesicles in mCRPC patients captures cancer cells and tumor microenvironment signalspreprint
    2026-09-07· bioRxiv· Vannuccini F et al.Enzalutamide
31. Pharmacologic Targeting of ZNF281 Suppresses Metastatic Prostate Cancer Beyond Androgen Receptor Dependencepreprint
    2026-09-07· bioRxiv· Huang G et al.EnzalutamideAzacitidineDecitabine + cedazuridine
32. Utility of Chemotherapy for Metastatic Melanoma in the Contemporary Era and Experience with Modified Vinblastine-Cisplatin-Temozolomide at a Tertiary Care Centerpreprint
    2026-09-07· Preprints.org· Doolittle WKL et al.TemozolomideCisplatin
33. Tumor angiogenesis proteome dynamic changes across different grades of gliomas: Analysis within the framework of 3P medical approachespreprint
    2026-09-07· Research Square· Li Z et al.TemozolomideBevacizumabBevacizumabBTK
34. BMPR1B in TAMs promoted Oral Squamous Cell Carcinoma via increasing SMAD1/EGR1/PD-L1/XBP-1 signaling induced M2 polarizationpreprint
    2026-09-07· Research Square· Zhuang Z et al.PertuzumabAzacitidineDecitabine + cedazuridine
35. Repeated Oral Manganese Exposure-Associated Hepatorenal Injury in BALB/c Mice: Integrated Evidence from Tissue Accumulation, Redox Imbalance, Inflammation, and Histopathologypreprint
    2026-09-07· Research Square· Idowu OK et al.AzacitidineDecitabine + cedazuridine
36. Venetoclax-based Therapy Improves Outcomes across the Evolving Biology of t(11;14) Multiple Myelomapreprint
    2026-09-07· medRxiv· Sudalagunta PR et al.LenalidomideDaratumumab
37. A real-world disproportionality analysis of adverse events associated with lenvatinib in thyroid cancer patients based on the FAERS databasepreprint
    2026-09-06· Research Square· zeng x et al.Lenvatinib
38. Cell-cycle control of chromatin creates a therapeutic window for epigenetic therapy in tumorspreprint
    2026-09-06· bioRxiv· Hayatigolkhatmi K et al.Cisplatin
39. CT-Based Habitat Radiomics and Deep Learning for Predicting Early Response and Survival in Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy plus Lenvatinib and Programmed Death Receptor-1 Inhibitorspreprint
    2026-09-05· Research Square· Bao W et al.LenvatinibFOLFOXCytarabine + anthracycline
40. Comparative Dosing of Bevacizumab for Radiation Necrosis: Impact of Tumor Type on Edema Responsepreprint
    2026-09-04· Research Square· Schultz SE et al.BevacizumabBevacizumab
41. Molecular Heterogeneity and Organoid-Based Therapeutic Vulnerabilities of PIK3CA-Mutant Gastric Cancerpreprint
    2026-09-04· Research Square· Fu Y et al.Alpelisib
42. Safety and efficacy of pertuzumab and trastuzumab in patients with HER2-Positive metastatic colorectal cancer: comparison of intravenous and subcutaneous formulations. ​preprint
    2026-09-04· Research Square· Furuoka M et al.Pertuzumab
43. A Nomogram for Predicting Chemotherapy-Induced Myelosuppression Risk in Colorectal Cancer Patientspreprint
    2026-09-04· Research Square· Yue Z et al.CetuximabCytarabine + anthracycline
44. Multi-Level Drivers of Colorectal Cancer Screening Uptake in the Gaza Strip: A Qualitative Focus Group Studypreprint
    2026-09-04· Research Square· Beram A et al.Colorectal cancer screening
45. Robust and Quality-of-Life-Aware Treatment Protocols in NSCLC using Deep Reinforcement Learningpreprint
    2026-09-04· bioRxiv· Jansén-Storbacka LR et al.Nintedanib
46. Real World Outcomes and Predictive Factors of Pirtobrutinib in Mantle Cell Lymphoma After Failure of Covalent Bruton Tyrosine Kinase Inhibitorspreprint
    2026-09-04· Research Square· Phillips T et al.BTKPirtobrutinib
47. Integrated single-cell and bulk transcriptomes identify glycosylation-associated prognostic markers for anti-PD-1 response in liver cancerpreprint
    2026-09-04· Research Square· Yang N et al.Bortezomib
48. Treatment Sequencing in ARPI-Pre-Exposed Metastatic Castration-Resistant Prostate Cancer: Radioligand Therapy, PARP Inhibitors, and Antibody–Drug Conjugatespreprint
    2026-09-03· Preprints.org· Sharaf B et al.DocetaxelCabazitaxel
49. CrcBiomeScreen: a reproducible workflow for class imbalance and cross-cohort generalisability in colorectal cancer microbiome predictionpreprint
    2026-09-03· Research Square· Li C et al.Colorectal cancer screening
50. Circulating Tumor DNA and Lung Cancer: Current and Future Perspectivespreprint
    2026-09-03· Preprints.org· Fotopoulos G et al.Nintedanib
51. No Overall Survival Benefit with Adding Chemotherapy to Immunotherapy in PD-L1 TPS ≥ 50% NSCLC: An Agent-Stratified Reassessmentpreprint
    2026-09-03· medRxiv· Han F et al.Nintedanib
52. Network Pharmacology and Multi-Dataset Validation Reveal the Therapeutic Mechanism of Curcumin against Non-Small Cell Lung Cancerpreprint
    2026-09-03· Research Square· Fatima A et al.Nintedanib
53. Toddaculin mediate the proliferation and migration of non-small cell lung cancer cells by regulating the GSH pathway through PTGS2preprint
    2026-09-03· Research Square· Li J et al.Nintedanib
54. Surgical and Pathological Outcomes of Lung Cancer Patients Who Did Not Radiologically Respond to Neoadjuvant Chemoimmunotherapypreprint
    2026-09-03· Preprints.org· Suda K et al.Nintedanib
55. Integrative single cell analysis of CD8+ T-cells across early and advanced oral cancers reveals signatures of anti-tumour activitypreprint
    2026-09-03· bioRxiv· Li CH et al.AzacitidineDecitabine + cedazuridine
56. A 10-year Cancer Registry Analysis on Demographic, Clinicopathological, and Treatment Characteristics for Head and Neck Cancer Patients in Zambiapreprint
    2026-09-03· Research Square· Mumena CH et al.AzacitidineDecitabine + cedazuridine
57. Gold-Decorated Carbon Dots Carrying Doxorubicin Enhance Tumor Selectivity in A549 Lung Cancer Cells Through Nucleus Targeting and Improved Loadingpreprint
    2026-09-03· Research Square· Saydullaeva I et al.Doxorubicin
58. Complementary cytotoxicity of GD2-targeted photoimmunotherapy and 5-aminolevulinic acid photodynamic therapy in neuroblastoma and osteosarcomapreprint
    2026-09-03· bioRxiv· Pant A et al.GD2
59. mTORC2 stabilizes HIF-1β to coordinate metabolic adaptation in lung cancerpreprint
    2026-09-03· bioRxiv· Paque M et al.KRAS
60. Systemic hypoxia drives glycogen-fueled progression of lung adenocarcinomapreprint
    2026-09-03· bioRxiv· Clarke HA et al.KRAS
61. Non-inferior survival and enhanced longevity with initial low-dose versus full-dose enzalutamide: a single-centre real-world prostate cancer studypreprint
    2026-09-02· medRxiv· Gorobets O et al.Enzalutamide
62. Identification of CRF-related molecular subtypes and development of a prognostic CRRS model in glioma: insights into immunotherapy response and biomarker discoverypreprint
    2026-09-02· Research Square· Xue J et al.Docetaxel
63. Omission of anthracyclines in HER2-positive Breast Cancer: A Retrospective Cohort Studypreprint
    2026-09-02· Research Square· Harman N et al.DocetaxelPertuzumab
64. Exploring the interaction between extracellular matrix components of bone marrow and prostate cancer cells in a novel 3D modelpreprint
    2026-09-02· Research Square· Yang J et al.Docetaxel
65. VITAL-3D: Volumetric Single-Cell Quantification Reveals Microenvironment-Dependent Drug Responses in Breast Cancerpreprint
    2026-09-02· bioRxiv· Jin C et al.Tamoxifen
66. From Housing to Hotspots: Integrating a Housing-Based Measure of Individual Socioeconomic Status with Geospatial Analysis to Target Colorectal Cancer Screening in Rural Communitiespreprint
    2026-09-02· medRxiv· Yao R et al.Colorectal cancer screening
67. DNA Damage Repair Pathway Mutations Do Not Predict Survival or Adjuvant Chemotherapy Benefit in Resectable Non-Small Cell Lung Cancer: A Multi-Cohort Analysispreprint
    2026-09-02· Research Square· Cai W et al.Nintedanib
68. Nuclear Myosin VI stabilises Ku-associated DNA ends during nonhomologous end joiningpreprint
    2026-09-02· bioRxiv· Alanazi AF et al.Cisplatin
69. A Case Report and Literature Review of Extraskeletal Osteosarcoma of the Abdominal Wallpreprint
    2026-09-02· Research Square· Cai R et al.CisplatinIfosfamide
70. Chronic Psychological Stress and Cancerpreprint
    2026-09-02· Preprints.org· Satcau T et al.AzacitidineDecitabine + cedazuridine
71. Update of the EORTC Multiple Myeloma module (QLQ-MY20): Results from qualitative interviews with patients and healthcare professionalspreprint
    2026-09-02· Research Square· Kyriakou C et al.AzacitidineDecitabine + cedazuridine
72. Initial tumor composition shapes resistance evolution and treatment outcomes in non-small cell lung cancerpreprint
    2026-09-01· bioRxiv· Satouri M et al.AlectinibNintedanib
73. NAE1-Dependent Protein Neddylation Preserves Endothelial Identity and Vascular Integritypreprint
    2026-09-01· bioRxiv· Zoni RN et al.Tamoxifen
74. Oncolytic adenovirus encoding AEG1/CD3 bispecific T-cell engager potentiates antitumor immunity against lung cancerpreprint
    2026-09-01· Research Square· Tian J et al.PertuzumabNintedanib
75. Epigenetic Remodeling via ARID2 Knockdown Reveals Synergistic Sensitivity to BET and EGFR/HER2 Inhibition in 3D Melanoma Modelpreprint
    2026-09-01· Research Square· Zarnaghi BB et al.Lapatinib
76. Extreme Immune Checkpoint Inhibitor–Associated Thrombocytosis with Concurrent C-MET Upregulation Evolution in Extensive-Stage Small Cell Lung Cancer: A Case Reportpreprint
    2026-09-01· Research Square· Huang C et al.ToripalimabTislelizumab
77. Contrasting PD1 blockade responses and immunogenomic contexts in MSI high rectosigmoid adenocarcinomaspreprint
    2026-09-01· Research Square· Zhang S et al.TislelizumabKRAS
78. PD-1 versus PD-L1 inhibitors with consolidative thoracic radiotherapy in extensive-stage small cell lung cancer: a multicenter real-world cohort studypreprint
    2026-09-01· Research Square· Ji H et al.Platinum + etoposideCisplatin
79. A Mapping Study of EORTC QLQ-C30 to EQ-5D-5L among the Korean Patients with Non-Small Cell Lung Cancerpreprint
    2026-09-01· Research Square· Lee H et al.Nintedanib
80. Cost-Effectiveness of Erdafinib vs. Chemotherapy for Advanced or Metastatic Urothelial Carcinoma from the Payer Perspectives in the US and Chinapreprint
    2026-09-01· Research Square· Zhang B et al.Erdafitinib
81. Basal expression predicts context-specific drug responses only where they are reproducible: a leakage-safe 47-line LOCO benchmark on Tahoe-100Mpreprint
    2026-09-01· Research Square· Shen H.Selinexor
82. The trade-off between parsimony and model complexity for understanding biomedical mechanisms from mathematical modelspreprint
    2026-09-01· bioRxiv· Lamirande P et al.Cisplatin
83. Immunizing small cell lung cancer mice with isoaspartylated Elavl4 after chemotherapy mimics improved survival of anti-ELAVL4 antibody-positive small cell lung cancer patientspreprint
    2026-09-01· bioRxiv· Velarde DA et al.Cisplatin
84. ZNF384-r in Pediatric BCP-ALLpreprint
    2026-09-01· Research Square· Zhao Y et al.KMT2A
85. Consumption of Different Meat Types and the Cumulative Incidence of 18 Common Cancers Worldwide: An Ecological Analysispreprint
    2026-09-01· Research Square· Amini MM et al.AzacitidineDecitabine + cedazuridine
86. A Steroid-Sparing Combination Regimen of Low-Dose Atorvastatin and Reduced-Dose Prednisolone Maximizes Healing in Experimental Ulcerative Colitispreprint
    2026-09-01· Research Square· Qaderi M et al.AzacitidineDecitabine + cedazuridine
87. Comparing the Efficacy of High-Power and Low-Power Laser Therapy in the Management of Chemotherapy-Induced Oral Mucositis in Pediatric Patients with Acute Lymphoblastic Leukemia: A Randomized Controlled Trialpreprint
    2026-09-01· Research Square· kassem L et al.AzacitidineDecitabine + cedazuridine
88. Investigating the effects of Orthosiphon stamineus on blood glucose regulation via pancreatic endocrine and exocrine functions in Type 3c Diabetes Mellitus Wistar Bonn/Kobori (WBN/Kob) pancreatitis rat model.preprint
    2026-09-01· F1000Res· Lokman EF et al.AzacitidineDecitabine + cedazuridine
89. Preoperative Prediction of Vascular Invasion in Breast Cancer Based on Habitat-Based Radiomics Integrating Intratumoral and Multidimensional Peritumoral Features: A Multicenter DCE-MRI Studypreprint
    2026-09-01· Research Square· Li H et al.Cytarabine + anthracycline
90. Mycosis Fungoides with Large-Cell Transformation Metastatic to the Central Nervous Systempreprint
    2026-09-01· Research Square· Neisani MA et al.CD30
91. Glioblastoma Tumors with Decelerated Epigenetic Aging Are Characterized by Glutamatergic Neuronal Activity and Stemnesspreprint
    2026-08-31· bioRxiv· Motevasseli M et al.Temozolomide
92. Bevacizumab, Pembrolizumab, and Low-Dose Capecitabine in Refractory Metastatic Gastrointestinal Cancers: A Retrospective Real-World Analysispreprint
    2026-08-31· Research Square· Hoffmeister P et al.BevacizumabBevacizumab
93. The Landscape of Clinical Trials for Antibody-Drug Conjugates in the Treatment of Ovarian Cancerpreprint
    2026-08-31· Research Square· chen h et al.BevacizumabBevacizumab
94. Melatonin nanoparticles inhibit mutant hematopoiesis & restore bone marrow architecture in myeloproliferative neoplasmspreprint
    2026-08-31· bioRxiv· Gupta S et al.Tamoxifen
95. Evaluation of Estrogen Responsiveness and Sensitivity to Endocrine Therapy in ER-Positive Breast Cancer Organoids Using an Optimized Culture Mediumpreprint
    2026-08-31· Research Square· Uematsu H et al.Tamoxifen
96. Patient and Healthcare Professional Experience with Fixed-Dose Subcutaneous Pertuzumab and Trastuzumab (PHESGO) in a High-Volume Oncology Center in Vietnam: A Real-World Study from a Resource-Constrained Settingpreprint
    2026-08-31· Research Square· Duc PTH et al.Pertuzumab
97. Access Without Equity: Income-Related Inequities in Preventive Care Across Europe- a cross-sectional studypreprint
    2026-08-31· Research Square· Silva¹ AMP et al.Colorectal cancer screening
98. Massive Ascites Mimicking Progressive Disease During Zolbetuximab Treatment in Claudin 18.2-Positive Advanced Gastric Cancer: A Case Reportpreprint
    2026-08-31· Research Square· Ishizuka C et al.Zolbetuximab
99. Safety and Antitumor Activity of the Usnic Acid Derivative OL9‑116, a TDP1 Inhibitor, as an Adjunctive Therapy in Combination with Topotecanpreprint
    2026-08-31· Preprints.org· Kornienko TE et al.Topotecan
100. BCL2L13 attenuation links impaired mitophagy to epithelial plasticity and anoikis tolerance in lung adenocarcinomapreprint
     2026-08-31· bioRxiv· Alizadeh J et al.Nintedanib
101. Point-of-Care Breath Volatile Organic Compound Analysis as a Tool for Lung Cancer Screening: A Pilot Feasibility Studypreprint
     2026-08-31· medRxiv· Pichkar Y et al.Nintedanib
102. Single-Cell Dissection of Cisplatin-Resistant Muscle-Invasive Bladder Cancer Reveals Adaptive States and Therapeutic Vulnerabilitiespreprint
     2026-08-31· Research Square· Han J et al.Cisplatin
103. RedFuMOS: A novel approach for multi <i>-omics</i> and clinical data-driven patient stratificationpreprint
     2026-08-31· medRxiv· De Luca S et al.BCR::ABL1
104. Benchmarking the Intratumoral Microbiome in Pancreatic Ductal Adenocarcinoma: A Longitudinal Assessment of Contamination Sources and Decontamination Strategiespreprint
     2026-08-31· bioRxiv· Dang L et al.AzacitidineDecitabine + cedazuridineKRAS
105. Osteoradionecrosis Following Exclusive Intensity-Modulated Proton Therapy for Oral Cavity and Oropharyngeal Cancerpreprint
     2026-08-31· Research Square· Chang DY et al.AzacitidineDecitabine + cedazuridine
106. Role of H2AX and p53 in Various Grades of Oral Submucous Fibrosis (OSF) in Malignant Transformation: A Cross-sectional studypreprint
     2026-08-31· Research Square· Bhupesh B et al.AzacitidineDecitabine + cedazuridine
107. Implementation of a Structured Same-Day Discharge Pathway Following Robot-Assisted Radical Prostatectomy: A Pilot Study from a Latin American Cancer Centerpreprint
     2026-08-31· Research Square· Neto PRP et al.AzacitidineDecitabine + cedazuridine
108. Early Proteinuria as a Predictor of Renal Dysfunction following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemiapreprint
     2026-08-31· Research Square· Schwarz F et al.Cytarabine + anthracycline
109. Extracellular Volume Fraction Derived from Contrast-Enhanced CT for Predicting Occult Lymph Node Metastasis in Colorectal Cancerpreprint
     2026-08-31· Research Square· Ma J et al.Cytarabine + anthracycline
110. ZNF217-USP15 signaling loop regulates oncogenic phenotypes in ovarian cancer cellspreprint
     2026-08-31· bioRxiv· Ogunsanya A et al.Doxorubicin
111. Epithelioid Sarcoma of the Right Forearm With Pulmonary Metastases and Suspected Cardiac Involvement: A Case Reportpreprint
     2026-08-31· Research Square· Gan H et al.DoxorubicinIfosfamide
112. Development and Optimization of ¹¹¹ In-Dinutuximab-IRDye800, a Dual-Modality Intraoperative Molecular Imaging Agent for Pediatric Neuroblastoma Resectionpreprint
     2026-08-31· bioRxiv· Yip CY et al.GD2
113. Survivin Promotes the Formation of a Microtubule-Based Glycolytic Hubpreprint
     2026-08-31· bioRxiv· Neumann J et al.KRAS
114. Bacterial metagenome in plaque, saliva, and tumor samples from individuals with and without OSCC by next-generation sequencingpreprint
     2026-08-29· bioRxiv· Erira A et al.AzacitidineDecitabine + cedazuridine
115. Diagnostic Performance of a Combined KLK2, miR-21, PSA, CRP, Albumin, AGR, and GGT Biomarker Panel for Distinguishing Prostate Cancer from Benign Prostatic Hyperplasia in Nigerian Menpreprint
     2026-08-28· Research Square· Adekola SA et al.KLK2
116. Core Needle Biopsy-Derived Organoids for Docetaxel Sensitivity Assessment in HR-Positive/HER2- Negative Breast Cancer: Exploratory Implications of Morphology and Treatment-Induced TUBB3 Dynamic Patternspreprint
     2026-08-28· Research Square· Gao¹ D et al.Docetaxel
117. Immune Activation and Candidate Prognostic Marker Discovery in Bladder Cancer: A Preclinical Mouse Study of Recombinant M. smegmatispreprint
     2026-08-28· Research Square· Song D et al.Pertuzumab
118. Advances in Interventional Oncology for Hepatocellular Carcinomapreprint
     2026-08-28· Preprints.org· Gadani S et al.Transarterial chemoembolisation
119. Spatially resolved transcriptional programs link fallopian tube precursor lesions to immune activation and stromal reorganizationpreprint
     2026-08-28· bioRxiv· Recouvreux MS et al.PRAME
120. Comprehensive genomic profiling-guided treatment selection in appendiceal adenocarcinoma with discordant mismatch repair findings: a case report and literature reviewpreprint
     2026-08-28· Research Square· Ando T et al.PanitumumabFOLFOX
121. Colorectal Cancer Screening Communication and Completion Among Black and Hispanic Primary Care Patientspreprint
     2026-08-28· Research Square· Rivera JNR et al.Colorectal cancer screening
122. STING Expression Progressively Increases During Esophageal Squamous Carcinogenesis but Predicts Favorable Outcome After Endoscopic Resection: A Paradox Resolved by Context-Dependent Immunitypreprint
     2026-08-28· Research Square· Wang B et al.Endoscopic resection
123. Carboplatin inhibits NSCLC growth and is associated with alterations in HMGB1 expression and macrophage polarizationpreprint
     2026-08-28· Research Square· Li H et al.Nintedanib
124. U1 snRNA blockade regulates DNA repair genes, DNA damage, and cisplatin sensitivity of lung cancer cellspreprint
     2026-08-28· bioRxiv· Devaux A et al.Cisplatin
125. The DE-RADIATE study: a prospective, single arm trial of radical radiation dose de- escalation in HPV-associated oropharyngeal squamous cell carcinoma using F-MISO/PET as a biomarker of hypoxiapreprint
     2026-08-28· Research Square· Lawless AK et al.Cisplatin
126. Loss to Follow-Up Among Patients with Kaposi Sarcoma at the Ocean Road Cancer Institute, Tanzania: A Fine–Gray Competing-Risks Analysis of Death as a Competing Eventpreprint
     2026-08-28· medRxiv· Lugina EL et al.AzacitidineDecitabine + cedazuridine
127. Cross-cohort oral microbiome meta-analysis identifies shared OPMD-OSCC dysbiosis while machine learning exposes limits of OSCC classifier transportabilitypreprint
     2026-08-28· bioRxiv· Shi H et al.AzacitidineDecitabine + cedazuridine
128. A 16-colour spectral flow cytometry panel to characterise T cell immunophenotypes in canine oral melanomapreprint
     2026-08-28· bioRxiv· Hindriks E et al.AzacitidineDecitabine + cedazuridine
129. A prospective multicenter cohort study of Ninjin-yo’eitou for fatigue, malaise, anorexia and anemia during Olaparib treatment in patients with ovarian cancer: the KCOG-G1904 studypreprint
     2026-08-28· Research Square· Fujiwara S et al.AzacitidineDecitabine + cedazuridine
130. Protective Effect of Oral Antidiabetic Medicines Against Mechanical Ileus Development and Its Impact on Metastatic Colon Cancer Survivalpreprint
     2026-08-28· Research Square· Özgül D et al.AzacitidineDecitabine + cedazuridine
131. Primary ALK-Positive Anaplastic Large Cell Lymphoma of the Urinary Bladder in a Pediatric Patient: A Case Report and Review of Literaturepreprint
     2026-08-28· Research Square· Kaur N et al.CD30
132. Single-atom inhibition of oncogenic drivers through cysteine coordinationpreprint
     2026-08-28· bioRxiv· Zhao W et al.KRAS
133. Response-Adapted Bladder Preservation in Muscle-Invasive Bladder Cancer: Results of the Phase II RETAIN-2 Trial and Analysis of ctDNA Dynamicspreprint
     2026-08-27· medRxiv· Ghatalia P et al.Active surveillanceCisplatinDoxorubicin
134. Multicohort genomic-transcriptomic analyses uncover genetic drivers and therapeutic vulnerabilities in prostate cancerpreprint
     2026-08-27· Research Square· Wei G et al.Enzalutamide
135. CCL20–CCR6 Signaling as a Prognostic Biomarker and Therapeutic Target in Temozolomide-Resistant Glioblastomapreprint
     2026-08-27· bioRxiv· Green R et al.Temozolomide
136. Pharmacologic decoupling of IRBC activation from anabolic collapse redefines ribosome biogenesis inhibition as a selective tumor suppressive strategypreprint
     2026-08-27· bioRxiv· Menoyo S et al.FOLFOX
137. Endoscopic Resection of a Giant Pedunculated Leiomyoma in the Sigmoid Colon: A Case Reportpreprint
     2026-08-27· Research Square· Lin J et al.Endoscopic resection
138. Toward uncertainty-aware clinical decision support for treatment response prediction in metastatic NSCLC: integrating FDG-PET, T-cell repertoire, and cytokines with conformal predictionpreprint
     2026-08-27· Research Square· Yaseen F et al.PemetrexedNintedanib
139. HHV8-Associated Multicentric Castleman Disease with Kaposi Sarcoma in an Immunocompetent Patient: A Case Report and Review of the Literaturepreprint
     2026-08-27· Research Square· Hoerschgen K et al.KMT2ARituximabDoxorubicin
140. Biological Characteristics, Clinical Outcomes, and Therapeutic Strategies of NPM1-MLF1-Positive Acute Myeloid Leukemiapreprint
     2026-08-27· Research Square· Luo D et al.NPM1 mutation
141. Network Pharmacology and Molecular Mechanisms of Astragalus membranaceus (Huangqi) Targeting Kinase Pathways in Oncological, Cardiovascular, and Metabolic Diseasespreprint
     2026-08-27· Research Square· Abdullayev A.AzacitidineDecitabine + cedazuridine
142. A CTLA4–TIGIT Prognostic Signature and Checkpoint Blockade Efficacy in Oral Squamous Cell Carcinomapreprint
     2026-08-27· Research Square· Li X et al.AzacitidineDecitabine + cedazuridine
143. Supplementation Is Associated with Improved Body Composition and Clinical Recovery in Patients Undergoing Esophagectomy: A Prospective Controlled Pilot Studypreprint
     2026-08-27· Research Square· Xu L et al.AzacitidineDecitabine + cedazuridine
144. Glutamine stress promotes metastatic potential via hexosamine biosynthetic pathway activity in KRAS/STK11-mutant lung adenocarcinomapreprint
     2026-08-27· Research Square· Deming P et al.KRAS
145. Interpretable Forecasting of Kidney Cancer Progression via Generative AI and Symbolic Reasoningpreprint
     2026-08-26· bioRxiv· Prol-Castelo G et al.Active surveillance
146. DACH1 expression is inversely associated with promoter methylation of CADM1, ESR1, and SLIT2 in TCGA cervical squamous carcinoma: a network-based candidate regulator discoverypreprint
     2026-08-26· Research Square· Bird J.Abiraterone acetateDocetaxelCisplatin
147. Immune checkpoint inhibitors affect the potency of chemotherapeutic drugs in head and neck squamous cell carcinoma linespreprint
     2026-08-26· Research Square· Kase S et al.DocetaxelCisplatin
148. VEGFR-2 Phosphorylation at Y1054 or Y1214 is Necessary for Mechanically-Induced Angiogenesispreprint
     2026-08-26· bioRxiv· Johnson BM et al.BevacizumabBevacizumab
149. CONUT Score and CT-Derived Body Composition Parameters Predict Outcomes in Older Adults with AML and MDS Treated with Low-Intensity Therapypreprint
     2026-08-26· Research Square· Cabello-Modesto D et al.PertuzumabAzacitidine
150. An MLL-Independent Function of Menin Promotes Resistance to MAPK-Targeted Therapypreprint
     2026-08-26· bioRxiv· Srivaths A et al.Cetuximab

Showing the 150 most recent of 604; the per-topic sections below list the rest.

By topic